Asosiy kontentga oʻtish
AkademIndex

Xizmatlar

← Ishga qaytish

Ushbu ish iqtibos qilgan ishlar

37 ta ish

Ish: Trends, Characteristics and Treatment Outcomes of Patients with Drug-Resistant Tuberculosis in Uzbekistan: 2013–2018

  1. Multidrug-resistant tuberculosis in Uzbekistan: results of a nationwide survey, 2010 to 2011

    Dilrabo Ulmasova, G Uzakova, M N Tillyashayhov +17

    MaqolaOchiq kirishTuberculosis Research and EpidemiologyEurosurveillance201315 iqtibos
    ABI

  2. Multidrug-Resistant Tuberculosis Treatment Outcomes in Karakalpakstan, Uzbekistan: Treatment Complexity and XDR-TB among Treatment Failures

    Helen Cox, Stobdan Kalon, Sholpan Allamuratova +6

    MaqolaOchiq kirish200713 iqtibos
    ABI

  3. Uzbekistan: health system review.

    Mohir Ahmedov, Ravshan Azimov, Zulkhumor Mutalova +3

    MaqolaHealthcare Systems and ReformsPubMed201413 iqtibos
    ABI

  4. Short, Highly Effective, and Inexpensive Standardized Treatment of Multidrug-resistant Tuberculosis

    Armand Van Deun, Aung Kya Jai Maug, Md Abdul Hamid Salim +4

    MaqolaOchiq kirish201012 iqtibos
    ABI

  5. Multidrug-resistant Tuberculosis in Central Asia

    Helen Cox, Juan Daniel Orozco, Roy Male +6

    MaqolaOchiq kirishTuberculosis Research and EpidemiologyEmerging infectious diseases20049 iqtibos
    ABI

  6. Treatment of Highly Drug-Resistant Pulmonary Tuberculosis

    Francesca Conradie, Andreas H. Diacon, Nosipho Ngubane +15

    MaqolaOchiq kirish20207 iqtibos
    ABI

  7. A Trial of a Shorter Regimen for Rifampin-Resistant Tuberculosis

    Andrew Nunn, Patrick Phillips, Sarah Meredith +16

    MaqolaOchiq kirish20196 iqtibos
    ABI

  8. Treatment outcome with a short multidrug-resistant tuberculosis regimen in nine African countries

    Arnaud Trébucq, V Schwoebel, Zacharie Kashongwe +15

    Maqola20176 iqtibos
    ABI

  9. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for Reporting Observational Studies

    Erik von Elm, Douglas G. Altman, Matthias Egger +4

    MaqolaOchiq kirish20076 iqtibos
    ABI

  10. Sarlavhasiz

    Boshqa6 iqtibos
    ABI

  11. An updated systematic review and meta-analysis for treatment of multidrug-resistant tuberculosis

    Mayara Lisboa Bastos, Zhiyi Lan, Dick Menzies

    Sharh maqolaOchiq kirish20174 iqtibos
    ABI

  12. Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis

    Nafees Ahmad, Shama D. Ahuja, Onno W. Akkerman +97

    Sharh maqolaOchiq kirish20184 iqtibos
    ABI

  13. Risk Factors Associated with Default from Multi- and Extensively Drug-Resistant Tuberculosis Treatment, Uzbekistan: A Retrospective Cohort Analysis

    Maeve K. Lalor, Jane Greig, Sholpan Allamuratova +6

    MaqolaOchiq kirish20134 iqtibos
    ABI

  14. Why do tuberculosis patients default in Tashkent City, Uzbekistan? A qualitative study.

    Epco Hasker, Maksad Khodjikhanov, S Sayfiddinova +7

    Maqola20104 iqtibos
    ABI

  15. Rapid Molecular Detection of Tuberculosis and Rifampin Resistance

    Catharina Boehme, Pamela Nabeta, Doris Hillemann +16

    MaqolaOchiq kirish20104 iqtibos
    ABI

  16. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for reporting observational studies

    Erik von Elm, Douglas G. Altman, Matthias Egger +3

    MaqolaOchiq kirish20143 iqtibos
    ABI

  17. Modelling the effect of short-course multidrug-resistant tuberculosis treatment in Karakalpakstan, Uzbekistan

    James M. Trauer, Jay Achar, Nargiza Parpieva +7

    MaqolaOchiq kirishTuberculosis Research and EpidemiologyBMC Medicine20163 iqtibos
    ABI

  18. Person-centred care in practice: perspectives from a short course regimen for multi-drug resistant tuberculosis in Karakalpakstan, Uzbekistan

    Shona Horter, Beverley Stringer, Nell Gray +5

    MaqolaOchiq kirishTuberculosis Research and EpidemiologyBMC Infectious Diseases20203 iqtibos
    ABI

  19. The impact of diabetes on tuberculosis treatment outcomes: A systematic review

    Meghan A. Baker, Anthony Harries, Christie Y. Jeon +6

    Sharh maqolaOchiq kirish20112 iqtibos
    ABI

  20. Tuberculosis control in prisons: current situation and research gaps

    Masoud Dara, Colleen Acosta, Natalie V. S. Vinkeles Melchers +8

    Sharh maqolaOchiq kirish20152 iqtibos
    ABI

  21. A Prospective Study of the Risk of Tuberculosis among Intravenous Drug Users with Human Immunodeficiency Virus Infection

    Peter A. Selwyn, Diana Hartel, Victor Lewis +5

    Maqola19892 iqtibos
    ABI

  22. Tuberculosis, social determinants and co-morbidities (including HIV)

    Raquel Duarte, Knut Lönnroth, Cláudia Carvalho +4

    Sharh maqolaOchiq kirish20172 iqtibos
    ABI

  23. Challenges and Progress with Diagnosing Pulmonary Tuberculosis in Low- and Middle-Income Countries

    Anthony Harries, Ajay Kumar

    Sharh maqolaOchiq kirish20182 iqtibos
    ABI

  24. Management of drug-resistant tuberculosis

    Christoph Lange, Keertan Dheda, Dumitru Chesov +3

    Sharh maqolaOchiq kirish20192 iqtibos
    ABI

  25. Drug-resistant tuberculosis in eastern Europe and central Asia: a time-series analysis of routine surveillance data

    Andrei Dadu, Arax Hovhannesyan, Sevim Ahmedov +2

    Maqola20192 iqtibos
    ABI